Navigation Links
Anemia Drugs to Be Taken With Caution

A trial of Aranesp an anemia drug from Amgen Inc disclosed a rise in number of deaths especially in advanced cancer patients. This has reiterated the fact// that such drugs should be prescribed in restricted conditions only.

The mode of action of Aranesp is based on the natural protein called erythropoietin (EPO) which augments the production of red blood corpuscles in the body. This drug is the major product of Amgen Inc and has also been permitted to treat in conditions of anemia caused by chemotherapy and renal failure patients.

According to Roger Perlmutter, Amgen Inc.’s Executive Vice President for Research and Development, this drug if used within the specified indications is bound to be safe.

Generally EPO drugs are meant for people undertaking chemotherapy or radiation. But as per Amgen, this drug has also been prescribed for patients who are not undergoing chemotherapy or radiation.

Hence clear information on the conditions in which these EPO drugs to be used would surely benefit the patient and the health care community.


JYT
'"/>




Page: 1

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
5. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
6. Treatment of Sickle Cell Anemia Using Gene Therapy.
7. Treating Sickle Cell Anemia using Healthy Stem Cells
8. Anemia from Malaria Linked to a Protein MIF
9. EPO Effective For Cancer Patients Suffering From Anemia
10. Amgen introduces Autoinjector For Treating Anemia
11. Anemia Affects Both Body and Mind
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... more flexibility in repaying their loans, more information about their loan terms and ... total outstanding student loan debt, including federal and private loans, has reached $1.3 ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Spine Team ... pain, is proud to announce one of their physicians has been invited to be ... Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology: